Other
Fasting-mimicking diet
Fasting-mimicking diet is an intervention with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_2
4
80%
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(1)
Other(2)
Detailed Status
Recruiting2
unknown2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 24 (80.0%)
N/A1 (20.0%)
Trials by Status
recruiting240%
unknown240%
completed120%
Recent Activity
2 active trials
Showing 5 of 5
recruitingphase_2
FMD and Neoadjuvant Chemo-immunotherapy in TNBC
NCT07378306
recruitingphase_2
LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
NCT06831955
unknownphase_2
Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer
NCT04248998
completednot_applicable
Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)
NCT03700437
unknownphase_2
Metformin Plus/Minus Fasting Mimicking Diet to Target the Metabolic Vulnerabilities of LKB1-inactive Lung Adenocarcinoma
NCT03709147
Clinical Trials (5)
Showing 5 of 5 trials
NCT07378306Phase 2
FMD and Neoadjuvant Chemo-immunotherapy in TNBC
NCT06831955Phase 2
LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
NCT04248998Phase 2
Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer
NCT03700437Not Applicable
Fasting-mimicking Diet With Chemo-immunotherapy in Non-small Cell Lung Cancer (NSCLC)
NCT03709147Phase 2
Metformin Plus/Minus Fasting Mimicking Diet to Target the Metabolic Vulnerabilities of LKB1-inactive Lung Adenocarcinoma
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5